FindTrial
Sign In

The cellular and molecular biological characteristics of cancer patient-derived tumor organoids and clinical application study of drug sensitivity

The cellular and molecular biological characteristics of cancer patient-derived tumor organoids and clinical application study of drug sensitivity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106393
Enrollment
Unknown
Registered
2025-07-23
Start date
2024-05-13
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric and intestinal tumors

Interventions

Observation group:None

Sponsors

Changzhou Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) No history of other systemic malignant tumor diseases; 2) The intraoperative or postoperative pathological diagnosis was gastric or intestinal cell carcinoma.

Exclusion criteria

Exclusion criteria: Have a history of infectious diseases.

Design outcomes

Primary

MeasureTime frame
Success rate of organoid culture;—

Secondary

MeasureTime frame
HE staining of organoids;—

Countries

China

Contacts

Public ContactShao Fang

Changzhou Second People's Hospital

fuchenai@foxmail.com+86 137 7308 6070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026